Zeolitic Imidazolate Framework‐8 as pH‐Sensitive Nanocarrier for “Arsenic Trioxide” Drug Delivery

Previous results revealed that arsenic trioxide might be used as promising therapeutic agent for the treatment of some solid tumours as atypical teratoid rhabdoid tumours (ATRT). However, in order to become an approved drug for solid tumour treatment, the active formulation has to get more efficient...

Descripción completa

Detalles Bibliográficos
Autores principales: Ettlinger, Romy, Moreno, Natalia, Volkmer, Dirk, Kerl, Kornelius, Bunzen, Hana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856809/
https://www.ncbi.nlm.nih.gov/pubmed/31336004
http://dx.doi.org/10.1002/chem.201902599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856809/
https://www.ncbi.nlm.nih.gov/pubmed/31336004
http://dx.doi.org/10.1002/chem.201902599

Ejemplares similares